SCHEMBL16169689

SCHEMBL16169689

CCCCOc1cc(OCCCN)cc(-c2cc(C)c(F)c(-c3cc(-c4cc(OCCCN)cc(OCCCN)c4)cc(C)c3F)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.35
▸ CYP19A1 P11511 6/20 0.34
▸ CYP2C9 P11712 6/20 0.34
▸ CYP2C19 P33261 6/20 0.34
▸ CYP1A2 P05177 4/20 0.34
▸ RARA P10276 1/20 0.34
▸ RARB P10826 1/20 0.34
▸ CYP2D6 P10635 4/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ PLA2G2A P14555 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ CSF3R Q99062 1/20 0.32
▸ HTR1A P08908 1/20 0.32
▸ HTR1D P28221 1/20 0.32
▸ HTR1B P28222 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16172060 0.94 NOS3 (0.35) CSF3RPDK2
SCHEMBL16169683 0.83 PLA2G2A (0.43) CYP19A1CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL16169670 0.82 CYP1A2 (0.38) MCL1CYP19A1CYP2C9CYP2C19CYP1A2
SCHEMBL16169688 0.82 MCL1 (0.46) MCL1CYP19A1CYP2C9CYP2C19CYP1A2
SCHEMBL16169673 0.79 NOS3 (0.42) CYP19A1CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL18020389 0.78 PLA2G2A (0.47) CYP2C9CYP2C19CYP1A2CYP2D6CYP3A4
SCHEMBL16419735 0.75 CYP2D6 (0.45) CYP19A1CYP2C9CYP2C19CYP1A2RARA
SCHEMBL16419737 0.75 SMN1; SMN2 (0.48) CYP19A1CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL16169687 0.75 SMN1; SMN2 (0.48) CYP19A1CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL16172408 0.74 CSF3R (0.40) PLA2G2ACSF3RHTR1BPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140308317-A1 Polymeric Compounds And Methods Of Making And Using The Same CELLCEUTIX CORPORATION (US) 2014-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140308317-A1 Polymeric Compounds And Methods Of Making And Using The Same ALG1, CD44, MUC1 MCL1 24/4885CYP19A1 4661/4885CYP2C9 3475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback